Peer Review History

Original SubmissionMarch 9, 2021
Decision Letter - Walid Kamal Abdelbasset, Editor

PONE-D-21-07815

A national survey in United Arab Emirates on practice of passive range of motion by physiotherapists in intensive care unit

PLOS ONE

Dear Dr. Alaparthi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 13 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Walid Kamal Abdelbasset, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please upload a copy of the questionnaire as a supplemental file.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Reviewer comments:

Abstract:

1. The background of the study is too long and also not justified the research gap.

2. The methods section is missing the study design, study setting, and the study duration.

3. The results component should consist of the correlation between the passive movement and its improvement in joint range of motion.

4. The conclusion is not drawn on the basis of the results drawn.

Article

1. How come this study is differing from articles 9, 01, 11?

2. How come the UAE ethnicity and demographic characters are differed from England and Australia people?

3. Authors failed to find the research gap and its clinical significance.

4. Include the ethical committee name and its reference number.

5. Include the reliability and validity of the questionnaire used for this survey.

6. Include the name of the questionnaire.

7. Include the method used for finding the sample size?

8. Mention the statistical analysis performed for this survey.

9. The results component should consist of the correlation between the passive movement and its improvement in joint range of motion.

10. Mention the role of age, gender, educational qualification, years of experience etc… in physical therapy intervention.

11. The discussion part should define the mechanism, how passive movement improves patient’s symptoms in ICU with recent references.

12. Overall, this study is not scientifically strong and also technically week for publishing.

Reviewer #2: PLOS ONE REVIEW

Topic: A national survey in United Arab Emirates on practice of passive range of motion by physiotherapists in intensive care unit

Abstract

Line 33: Sample size extremely too small for a national survey.

Line 39: 51.6% is more than half and not almost half

Line 43: What assessment is being referred to? statement not clear.

Introduction

Line 78: Effects should be changed to Benefits

Materials and Methods

Line 110: was made should be changed to was developed.

Line 116: Reflection on their current practice is repeated. It is already written in line 113.

Lines 122-125: What are the exclusion criteria. This statement on inclusion criteria is not clear.

Lines 126-127: Was required sample size not calculated? What physiotherapy Groups exactly? This has to be clearly stated. Would the national licensing body not be better? Were they from both private and government hospitals?

Results

Line 140: Are there a total 54 ICU physiotherapist with at least one year experience?

Line 143: Table should be properly labelled as n (%), n, meaning frequency. The frequency data under age, gender and years of ICU experience do not add up to 33. The mean value for year of graduation says .3, I don’t know how that can be. The average duration of ICU stay should be clear if it was recorded in days, weeks or months. Under types of patients admitted to the ICU, Burns (the frequency and the percentage) was written twice. What is GCC Region? Please be clear on that. Generally, be consistent with the number of decimal points.

Line 148: What is Blanket referral? Please be clear on that.

Line 151: Please include the standard deviation to the mean of 3.75

Lines 166-168: It is good to clarify if the statement is per patient.

Line 182: Tables 2 and 3. S should be added to table.

Line 190 and 194: Tables should be better labelled to indicate that these figures are all frequencies. The coding is not clear.

Line 204: Percentage of 37.5 cannot be referred to as majority.

Line 206 and 207: The percentage calculation of 26 (81.3%) or 26 (96.3%) is not correct.

Line 212: Frequency of 10 cannot be referred to as most of the respondents. Frequency of 10 cannot give a percentage of 55,6.

Line 223: What percentage of the respondents reported contractures to be the major problem.

Line 238: Table should be better labelled to indicate that these figures are all frequencies. The coding should be made clearer.

Line 249: According to figure 4, we had both neurological condition and burns, can this be made clearer?

Line 260: Table should be better labelled to indicate that these figures are all frequencies. The coding should be made clearer.

Many of the percentage calculations are not correct. Some are lower, while some are higher.

It is difficult to ascertain the actual sample size, 30 0r 33. Please this has to be clear, what exactly is the sample size?

Discussion

Line 269: What is Blanket referral? Can it be reworded?

Line 270: What other staff? Doctors? other physiotherapist? It has to be clearly stated.

Line 315: Who are senior physiotherapist? By age or by cadre? Are senior Physiotherapists not included at all in this study.

Line 318-320: Could this be as a result of the mode of data collection? could it be that younger individuals generally have better reaction towards activities online?

Line 321: I am worried that the sample size of 33 or 30 may not represent the perception of ICU physiotherapists in the UAE.

What are the possible limitations to this study?

Any acknowledgements?

Figures

Can the bars on Fig 3 be better aligned?

Raw Data

Not available for review.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Ajepe, Titilope Oluwatobiloba

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Thank You for the corrections. We have tried our best to incorporate all the corrections. Please find attached the revised manuscript and response to reviewers file for your kind perusal.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Walid Kamal Abdelbasset, Editor

PONE-D-21-07815R1

A national survey in United Arab Emirates on practice of passive range of motion by physiotherapists in intensive care unit

PLOS ONE

Dear Dr. Alaparthi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Walid Kamal Abdelbasset, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Five new authors have been added to the authors list.

Each authors’ contribution should be explained. Please provide the authors’ contributions in line with ICMJE4 criteria.

The major concern in the study is the small sample size compared with the study design. The authors have to explain how did they calculate the sample size and power of the study?

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Thank You for your comments. We have provided explanation for your valuable comments.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Walid Kamal Abdelbasset, Editor

A national survey in United Arab Emirates on practice of passive range of motion by physiotherapists in intensive care unit

PONE-D-21-07815R2

Dear Dr. Alaparthi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Walid Kamal Abdelbasset, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Author,

I regret to say that this is a very outdated title, which could not be reviewed.

Regards

Reviewer #3: -

Reviewer #4: Dear authors of the manuscript entitled "A national survey in United Arab Emirates on practice of passive range of motion by physiotherapists in intensive care unit

" i found your article quite intresting, i have no comments and i believe that the manuscript is eligible for publication

best wishes

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

Reviewer #4: No

Formally Accepted
Acceptance Letter - Walid Kamal Abdelbasset, Editor

PONE-D-21-07815R2

A national survey in United Arab Emirates on practice of passive range of motion by physiotherapists in intensive care unit

Dear Dr. Alaparthi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Walid Kamal Abdelbasset

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .